Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

OrderlyMeds vs TeleCareSpot

OrderlyMeds
Graded #78

Higher grade

vs+4.700000000000003
TeleCareSpot
Graded #160

Lower grade

The verdict

OrderlyMeds takes it — 72.4/100 to 67.7/100.

OrderlyMeds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. OrderlyMeds is a telehealth provider selling compounded semaglutide and tirzepatide with no membership fees or hidden costs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOrderlyMeds +49
92
43
Dose & formulationTeleCareSpot +19
64
83
Clinical oversightTeleCareSpot +1
82
83
Labs & monitoringOrderlyMeds +1
53
52
FulfillmentTeleCareSpot +27
65
92
Contract termsTeleCareSpot +6
55
61
OrderlyMeds · left barTeleCareSpot · right bar

The numbers

MetricOrderlyMedsTeleCareSpot
WeighScore72.4/10067.7/100
GradeCC
Scorecard rank#78#160
Semaglutide$74/mo (starting dose, 2-mo starter plan, new patients only, compounded)$299/mo (all doses, plus a separate fee, compounded)
Tirzepatide$299/mo (compounded)$399/mo
CoverageCoverage not published48 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
OrderlyMeds

Graded #78 · C

Strengths

  • The starter rate and the standing rate are both published, so the step-up is visible before signing up
  • No membership fees and no hidden costs, stated as such
  • The dose ladder is published: four weeks at 0.25 mg then four weeks at 0.5 mg
  • Brand-name routes are priced openly, at retail

Where it loses points

  • The $74 rate is a two-month starter plan billed as $149 up front, and it is open only to patients new to GLP-1 medication; the standing monthly rate is $149
  • Tirzepatide has no equivalent standing discount — $299/mo is the ongoing rate
  • Brand-name routes are priced at retail: Wegovy $1,839 and Zepbound $1,498
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
TeleCareSpot

Graded #160 · C

Strengths

  • Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
  • Verifiable LegitScript certification (seal ID 45936855) plus HIPAA compliance and licensed US physicians
  • Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
  • DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
  • Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans

Where it loses points

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Not available in Alaska, Mississippi, or New Jersey
  • The compounding pharmacy partner is not named
  • A separate weight-loss consultation fee applies (credited toward your medication package if approved)
  • Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard